RARE Ultragenyx Pharmaceutical23.90-0.21 (-0.9%)
RARE Ultragenyx Pharmaceutical22.96-0.25 (-1.1%)
RARE Ultragenyx Pharmaceutical23.48+0.48 (+2.1%)
RARE Ultragenyx Pharmaceutical21.66+1.94 (+9.8%)
RARE Ultragenyx Pharmaceutical19.97-14.22 (-41.6%)
Premarket Decliner
RARE Ultragenyx Pharmaceutical34.19-0.39-1.1%
Premarket:17.95-16.24 (-47.5%)
Ultragenyx Announces Phase 3 Orbit and Cosmic Results for Setrusumab (UX143) in Osteogenesis Imperfecta
Globe NewswireMon, 29-Dec 8:30 AM